Search by keywords: and/or Explore by tags: Cancer CareCancer Care › Clinical TrialsCancer Care › DiagnosisCancer Care › Diagnosis › PathologyCancer Care › Genetic TestingCancer Care › Integrative MedicineCancer Care › Integrative Medicine › AcupunctureCancer Care › Medical TechnologyCancer Care › Medical Technology › Bone ScanCancer Care › Medical Technology › CTCancer Care › Medical Technology › MRICancer Care › NursingCancer Care › Pain ManagementCancer Care › Palliative CareCancer Care › Patient Care FacilitiesCancer Care › Prediction ToolsCancer Care › PreventionCancer Care › ScreeningCancer Care › Screening › ColonoscopyCancer Care › Screening › MammographyCancer Care › Screening › PSA TestingCancer Care › TreatmentCancer Care › Treatment › Blood & Marrow Stem Cell TransplantationCancer Care › Treatment › Plastic & Reconstructive SurgeryCancer Care › Treatment › Interventional Radiology Cancer Care › Treatment › Robotic SurgeryCancer Care › Treatment › ChemotherapyCancer Care › Treatment › Gene TherapyCancer Care › Treatment › Hormone TherapyCancer Care › Treatment › ImmunotherapyCancer Care › Treatment › Personalized MedicineCancer Care › Treatment › Radiation TherapyCancer Care › Treatment › SurgeryCancer Care › Treatment › Targeted TherapyCounseling & SupportCounseling & Support › CancerSmartCounseling & Support › Cognitive TestingCounseling & Support › PsychiatryCounseling & Support › Sexual HealthCounseling & Support › Social WorkCounseling & Support › Virtual ProgramsEducation & TrainingMiscellaneousMiscellaneous › FacebookMiscellaneous › WebsiteSurvivorshipSurvivorship › BridgesResearchResearch › Cancer Genetics & GenomicsResearch › Sloan Kettering InstituteResearch › Cancer Immunotherapy & VaccinesResearch › Cancer MetabolismResearch › CellBased TherapyResearch › Cell Signaling & RegulationResearch › Chemical BiologyResearch › Computational OncologyResearch › Developmental BiologyResearch › Discoveries & AdvancesResearch › Discoveries & Advances › Lab ResearchResearch › Discoveries & Advances › Clinical ResearchResearch › Discoveries & Advances › Health Outcomes, Epidemiology & StatisticsResearch › EpigeneticsResearch › Genome IntegrityResearch › Hematologic MalignanciesResearch › ImagingResearch › ImmunologyResearch › Metastasis & Drug ResistanceResearch › Microbiome & InflammationResearch › Molecular Pathology & DiagnosticsResearch › NanotechnologyResearch › Neuroscience & NeuroOncologyResearch › Solid Tumor OncogenesisResearch › Stem Cell BiologyResearch › Structural BiologyResearch › Systems BiologyResearch › Targeted TherapyResearch › Tumor MicroenvironmentGivingGiving › Donating BloodGiving › FundraisingGiving › The Society of MSKCCGiving › Volunteering Connect with us Sloan Kettering @GSKGradSchool Tweets by @GSKGradSchool 24 News Items found MSK Scientists Identify Rare (Rb-Proficient) Subtype of Small Cell Lung Cancer Tuesday, July 12, 2022 Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB. Q&A CAR T Cell Therapy Shows Promise for Treating Mesothelioma Thursday, July 29, 2021 A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma. Finding Many Mutations Detected in Liquid Biopsy Tests Do Not Come from Cancer Cells, an MSK Study Finds Monday, November 25, 2019 The new findings suggest the need for caution when interpreting the results from these tests. Finding Whether a BRCA Mutation Leads to Cancer Depends on Context, Study Finds Wednesday, July 10, 2019 Sometimes a BRCA mutation is just along for the ride, rather than driving a tumor’s development. Finding One Patient’s Exceptional Response Leads to a Surprising Discovery about Immunotherapy Tuesday, April 30, 2019 MSK researchers learn that some cancers may respond to checkpoint inhibitor drugs because of changes called gene fusions. Feature An Old Protein Gets a New Look: Researchers Target TGF-ß to Make Immunotherapy More Effective Friday, April 5, 2019 Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective. Finding Research Uncovers the Genetic Causes of Aggressive Leukemia in Children Monday, February 18, 2019 Researchers have found that the genetic changes that cause pediatric leukemia are different from those that lead to leukemia in adults. Roundup Top 10 Stories of 2018, Cancer Research Edition Thursday, December 27, 2018 Take a look back at some of the year’s biggest news in cancer research. Roundup Advances in Myeloma, Lymphoma, and Bone Marrow Transplant Announced at the 2018 ASH Meeting Monday, December 3, 2018 Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology. In the Clinic Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds Wednesday, November 28, 2018 The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer. In the Clinic Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects Wednesday, January 31, 2018 The study represents 20 years of research at MSK. In the News Year in Review: The Science and Technology that Shaped Cancer Care in 2017 Tuesday, December 5, 2017 As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year. In the Clinic Genetic ‘Scars’ Provide Clues for Tailoring Cancer Treatment Wednesday, October 11, 2017 For the first time, scientists have determined the extent of DNA repair deficiencies across cancer types. Learn what it means for patients. Finding Making an IMPACT: MSK’s Gene-Sequencing Test Reveals New Findings about Hereditary Cancer Risk Tuesday, September 5, 2017 An analysis of germline DNA in people with advanced cancer finds that inherited mutations may be more common than expected in this group. Announcement FDA Approves First CAR T Cell Therapy for Leukemia Wednesday, August 30, 2017 Children, teens, and young adults with leukemia that have stopped responding to chemotherapy are the first eligible to receive the new treatment. Announcement FDA Approves Enasidenib (Idhifa), a First-of-Its-Kind Drug, for Advanced Blood Cancer Wednesday, August 2, 2017 A new treatment option for people with acute myeloid leukemia is available, and it works in an unconventional way. In the Clinic The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers Friday, June 9, 2017 A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality. In the News #ASCO17: Post-Conference Roundup of Themes and Trends Wednesday, June 7, 2017 Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics. Feature With MSK Leading the Way, Precision Medicine Links Lab Research to Patient Care Thursday, February 9, 2017 Therapies that target genetic alterations in tumors are showing promise for many cancer patients, but challenges in developing these new treatments remain. Feature The Future of Cancer Research: Five Reasons for Optimism Tuesday, May 10, 2016 Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer. 1 2